SNRPC promotes chemoresistance in Wilms tumor via the NF-κB-CXCL17 axis regulating M2-Type TAMs infiltration and targeted nanotherapy research - PubMed
3 hours ago
- #Chemoresistance
- #Nanotherapy
- #Wilms Tumor
- SNRPC promotes chemoresistance in Wilms tumor via the NF-κB-CXCL17 axis.
- The study focuses on M2-Type Tumor-Associated Macrophages (TAMs) infiltration and targeted nanotherapy.
- Ethics approval was obtained from The Children’s Hospital of Chongqing Medical University.
- Animal experiments were approved by the same institution's ethics committee.
- The authors declare no competing interests.
- References include studies on Wilms tumor characteristics, relapse, and therapeutic vulnerabilities.